Dental robotics company completes approximately RMB 118 million in Series A Financing, advancing aesthetic veneer robotics technology.

DentalGoodNews｜On August 28, 2026, French dental robotics company Lupin Dental SAS (hereinafter referred to as "Lupin Dental") announced the successful completion of a €15 million (approximately RMB 118 million, based on the August 28, 2026 EUR/CNY central parity rate of €1 ≈ RMB 7.87) Series A Financing. This round was led by Fynveur with an investment of €10 million (approximately RMB 78.7 million), with participation from existing shareholders and new private investors, in addition to loan support from Bpifrance, the French national investment bank.

Founded in 2019 and headquartered in Montpellier, France, Lupin Dental was co-founded by aesthetic dentistry experts Dr. Galip Gürel and Dr. Stefen Koubi, according to official sources. The company focuses on developing dental robotics technology, aiming to introduce "supervised automation" into veneer and other complex dental treatments. Its core product, the Lupin robotic system, is a supervised automated robotic platform specifically designed for minimally invasive tooth preparation procedures for aesthetic veneers.

Image source: Lupin Dental SAS official website

According to official information, the Lupin robotic system has currently been approved for clinical use in India and the United Kingdom. In the Indian market, the technology is licensed to Dolphin Lifesciences LLC and is manufactured and distributed under the name Dolphin Robotic Dental System. However, the system has not yet been approved for clinical use in the United States or the European Union.

Following the completion of this financing round, Lupin Dental plans to further expand partnerships with leading academic medical institutions and dental professionals (including DSOs) to support the widespread application of its robotic technology globally. Meanwhile, Invus, the advisory firm of lead investor Fynveur, will join the Lupin Dental board of directors to provide strategic guidance and operational support to the company.